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NEW FINDINGS 23 
WHAT IS THE CENTRAL QUESTION OF THIS STUDY? 24 
Compared with Caucasians, African individuals are more susceptible to non-freezing 25 
cold injury and experience greater cutaneous vasoconstriction and cooler finger skin 26 
temperatures upon hand cooling. We investigated whether the enzyme cyclooxygenase 27 
is, in part, responsible for the exaggerated response to local cooling. 28 
 29 
WHAT IS THE MAIN FINDING AND ITS IMPORTANCE? 30 
2 
 
During local hand cooling, African descent individuals experienced significantly lower 1 
finger skin blood flow and skin temperature compared with Caucasians irrespective of 2 
cyclooxygenase inhibition. These data suggest that in young African males the 3 
cyclooxygenase pathway appears not to be the primary reason for the increased 4 
susceptibility to non-freezing cold injury. 5 
 6 
ABSTRACT 7 
African descent (AFD) individuals are more susceptible to non-freezing cold injury 8 
(NFCI) and experience an exaggerated cutaneous vasoconstrictor response to hand 9 
cooling compared with Caucasians (CAU). Using a placebo-controlled, crossover 10 
design, this study tested the hypothesis that cyclooxygenase (COX) may, in part, be 11 
responsible for the exaggerated vasoconstrictor response to local cooling in AFD. 12 
Twelve AFD and twelve CAU young healthy males completed foot cooling and hand 13 
cooling (separately, in 8 °C water for 30 minutes) with spontaneous rewarming in 30 °C 14 
air following placebo or aspirin (COX inhibition) treatment. Skin blood flow, expressed as 15 
cutaneous vascular conductance (CVC, flux•mmHg-1), and skin temperature (Tsk) were 16 
measured throughout. Irrespective of COX inhibition, the responses to foot cooling, but 17 
not hand cooling, were similar between ethnicities. Specifically, during hand cooling 18 
following placebo, AFD experienced a lower minimum skin blood flow (0.5 [0.1] vs. 0.8 19 
[0.2] flux•mmHg-1, P < 0.001) and a lower minimum finger Tsk (9.5 [1.4] °C vs. 10.7 [1.3] 20 
°C, P = 0.039) compared with CAU. During spontaneous rewarming average skin blood 21 
flow was also lower in AFD than CAU (2.8 [1.6] vs. 4.3 [1.0] flux•mmHg-1, P < 0.001). 22 
These data provide further support that AFD experience an exaggerated response to 23 
hand cooling and thus NFCI; however, the results demonstrate the COX pathway is not 24 
the primary reason for the exaggerated responses in AFD and increased susceptibility 25 
to NFCI.  26 
 27 
LIST OF ABBREVIATIONS 28 
AFD African descent 29 
AUC  Area under curve 30 
CAU Caucasian 31 
COX Cyclooxygenase 32 
3 
 
CVC Cutaneous vascular conductance 1 
IQR Interquartile range 2 
LDU  Laser Doppler units 3 
MAP Mean arterial pressure 4 
NFCI Non-freezing cold injury 5 
ROS Reactive oxygen species 6 
TXA2 Thromboxane A2  7 
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INTRODUCTION 1 
On initial whole-body cold exposure there is an immediate decrease in skin temperature 2 
(Tsk) which elicits local and centrally-induced constriction of the cutaneous circulation 3 
which serves as a defence mechanism, preventing heat loss from the body in an 4 
attempt to delay the onset of hypothermia (Spealman, 1945; Granberg, 1991; Kenney & 5 
Armstrong, 1996). In exchange for the protection of deep body temperature an 6 
individual is at risk of other cold injuries such as non-freezing cold injury (NFCI), with the 7 
feet more susceptible than the hands (Ungley & Blackwood, 1942). Symptoms of this 8 
injury often include pain, whilst mild cooling of the affected extremity is associated with 9 
an exaggerated vasoconstrictor response and slow rewarming which may leave an 10 
individual prone to further cold injuries. These symptoms may last for the remaining 11 
lifetime of an individual (Ungley et al., 1945). 12 
 13 
In the military population, particularly during conflict, cold injuries have resulted in 14 
hundreds of thousands of casualties (Paton, 2001; Golden et al., 2013). In the UK 15 
Armed Forces, between 2006 and 2016, there were 1,235 successful personnel 16 
compensation claims for NFCI, with the most recent year (March 2015–2016) costing 17 
the Ministry of Defence £1,486,200. However, NFCI is not solely a military problem as 18 
cases have been reported in civilians (Ramstead et al., 1980; Wrenn, 1991) and those 19 
who expose themselves to cold during leisure activities, such as mountaineering or cold 20 
expeditions (O’Brien & Frykman, 2003). Recently ‘Sport England’ (2016) reported nearly 21 
1.5 million individuals participate each month in sports which may involve cold exposure 22 
such as angling, water sports, mountaineering and snow sports, therefore the risk of 23 
NFCI is ever-present. 24 
 25 
A major predisposing risk factor on the incidence of NFCI is ethnicity. Individuals of 26 
African descent (AFD) are more susceptible to cold injuries compared with Caucasian 27 
individuals (CAU) under the same environmental conditions (DeGroot et al., 2003; 28 
Burgess & Macfarlane, 2009). Within the United States Armed Forces between 2009 29 
and 2014 there were 3,008 individuals who suffered a cold injury, with AFD injured at 30 
twice the rate of CAU (Connor, 2014). Despite increased awareness and education, 31 
NFCI and other cold injuries remain a current issue. 32 
 33 
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The mechanism(s) for the increased incidence of NFCI in AFD is not clear at present. 1 
During local hand cooling (8 °C for 30 minutes) and spontaneous rewarming we have 2 
previously observed that AFD experience greater vasoconstriction and also rewarm later 3 
and more slowly than CAU (Maley et al., 2014). The comparatively lower skin blood flow 4 
and lower Tsk in AFD may explain the increased susceptibility to NFCI. In addition we 5 
have shown that AFD appear to have a reduced endothelial function, showing a smaller 6 
vasodilatory response to ACh compared with CAU (Maley et al., 2015, 2017); however, 7 
the reason for the differences in response to local cooling remains unclear.  8 
 9 
During local cooling the decrease in skin blood flow is a result of sympathetic adrenergic 10 
activation releasing noradrenaline acting on post-synaptic adrenergic receptors (Pergola 11 
et al., 1993; Johnson et al., 2005), as well as an inhibition of nitric oxide production and 12 
contributions from non-adrenergic pathways (Hodges et al., 2006; Thompson-Torgerson 13 
et al., 2007; Johnson et al., 2014). Furthermore, cooling increases reactive oxygen 14 
species (ROS) (Bailey et al., 2005) which, along with reducing the bioavailability of nitric 15 
oxide, leads to translocation of α2C receptors to the cell surface, capable of exaggerating 16 
the response to local cooling (Chotani et al., 2000, 2004). Compared with CAU, in vivo 17 
and in vitro data demonstrates AFD experience heightened oxidative stress and 18 
reduced bioavailability of nitric oxide (Kalinowski et al., 2004; Feairheller et al., 2011). 19 
This oxidative stress may be produced from various sources such as nicotinamide 20 
adenine dinucleotide phosphate (NADPH) oxidase and cyclooxygenase (COX) (Kukreja 21 
et al., 1986; Griendling & FitzGerald, 2003; Vanhoutte, 2011). Along with other 22 
prostanoids, COX produces TXA2, a vasoconstrictor which plays a role in the cold-23 
induced vasoconstriction in response to hand cooling in those with Raynaud’s 24 
phenomenon (Tindall et al., 1985), demonstrating TXA2 may play a role in those with 25 
altered vascular function. Coupled with the information that AFD experience greater 26 
levels of oxidative stress, perhaps produced through COX, and that COX increases 27 
ROS and produces TXA2, it is possible that this enzyme may contribute to the 28 
accentuated vasoconstrictor response in AFD during local cooling.  29 
 30 
Therefore, the aim of the present study was to determine whether the accentuated 31 
vasoconstrictor response during local cooling and the delayed release during rewarming 32 
in AFD involves the COX pathway. It was hypothesised that COX inhibition would 33 
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attenuate the local cooling induced vasoconstriction and result in AFD experiencing 1 
local vascular responses similar to CAU. 2 
 3 
METHODS 4 
This study was given a favourable ethical opinion from the University of Portsmouth 5 
Science Faculty Ethics Committee and complied with standards set in ‘The Declaration 6 
of Helsinki’ (October 2013). The participants were made aware of the purpose, 7 
procedures and risks of the study prior to giving their informed written consent. Twelve 8 
CAU and 12 AFD male volunteers participated in the study; their physical characteristics 9 
are presented in Table 1. 10 
 11 
All CAU were born in the UK. Eight AFD were born in the UK whilst four were born in 12 
Africa (Zimbabwe, Ghana, Kenya and Uganda) and had resided in the UK for an 13 
average of 11 years, with a minimum of seven years. All participants were non-smokers, 14 
were free from asthma and any vascular or blood disorders including hypertension, 15 
diabetes and Raynaud's phenomenon, with no history of either freezing or non-freezing 16 
cold injuries. Participants’ history of cold exposure was ascertained by questionnaire 17 
with each ethnic group reporting similar exposure to cold. Ethnicity was determined by 18 
self-classification. To minimise heterogeneity, participants were only recruited if both 19 
parents and all four grandparents had known to originate from the same ethnic group. 20 
Prior to testing, participants were asked to refrain from consuming alcohol for 24 hours 21 
and participating in exercise or consuming caffeine for 12 hours. 22 
 23 
EXPERIMENTAL PROCEDURES AND MEASUREMENTS 24 
In a balanced, cross-over, placebo controlled design, participants were required to 25 
attend the laboratory on two separate occasions at the same time of day. Both visits 26 
included immersion of the foot and hand, separately, into cold water. As we previously 27 
observed no ethnic differences in Tsk and skin blood flow between ethnic groups in 28 
response to foot immersion in 15 °C water for two minutes (Maley et al., 2014), we 29 
decided to employ a cold-induced vasodilatation (CIVD) protocol, previously utilised 30 
(Maley et al., 2014), consisting of immersion in water at 8 °C for 30 minutes for both the 31 
foot and hand cooling. Previous research has demonstrated greater reactivity and 32 
comfort to 8 °C water compared with colder water (Mekjavic et al., 2013; Tyler et al., 33 
2015). For every participant, foot cooling was performed first followed by hand cooling. 34 
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 1 
Immediately prior to entering the climate controlled chamber participants were asked to 2 
consume 150 mL of diluted orange squash with or without soluble aspirin (acetylsalicylic 3 
acid; 600 mg, Boots Inc., UK), blinded to the participant. Aspirin irreversibly inhibits COX 4 
by acetylation of the active site of COX (Vane, 1971) with this dose of aspirin shown to 5 
inhibit 86 % of bradykinin-induced production of prostacyclin and 99 % inhibition of TXA2 6 
production by platelets at 30 minutes (Heavey et al., 1985).  7 
 8 
Participants entered the climate controlled chamber (mean [SD] Tdb: 30.3 [0.9] °C, Twb: 9 
22.9 [0.9] °C, WBGT: 25.1 [0.9] °C) removed their socks and shoes and rested in a 10 
semi-recumbent position for 25 minutes whilst being instrumented. A laser Doppler 11 
probe (VP1T / 7, Moor Instruments, UK) was applied to the Great toe of the right foot 12 
using double sided adhesive rings to measure skin blood flow using a laser Doppler 13 
flowmetry monitor (moorVMS-LDF, Moor Instruments, UK). Laser Doppler data were 14 
recorded using a data acquisition system and software (Powerlab and LabChart 7, AD 15 
Instruments, New Zealand). A thermistor (Type EUS-U, Grant Instruments, UK) was 16 
applied to the medial aspect of the Great toe pad of the right foot using a single piece of 17 
adhesive tape. Tsk was measured using a squirrel 1200 series data logger (Grant 18 
Instruments, UK) and recorded every five seconds.  19 
 20 
Following the 25-minute rest period participants placed their right foot into a plastic bag 21 
and immersed it up to the point of the mid-malleoli into a stirred water bath (Grant 22 
Instruments, UK) maintained at 35.0 (0.3) °C for five minutes. Following this, 23 
participants removed their foot, still within the plastic bag, and immediately placed it in a 24 
stirred water bath maintained at 8.2 (0.1) °C for a further 30 minutes. After foot cooling, 25 
participants removed their foot from the water bath and plastic bag to allow spontaneous 26 
rewarming of the foot for 15 minutes. Following this, participants were given 150 mL of 27 
diluted orange squash with or without soluble aspirin (300 mg). The reason for adding 28 
an extra dose of aspirin is due to the return of endothelial COX function within 90 29 
minutes and to ensure that COX function was inhibited as much as possible (Heavey et 30 
al., 1985). If a participant received aspirin at the beginning of the protocol they also 31 
received aspirin in their second drink; if the participant was not given aspirin in their first 32 
drink, then they were not given aspirin in their second drink (Fig. 1). 33 
 34 
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Within the next 25 minutes participants were instrumented for their hand immersion 1 
protocol. A laser Doppler probe and skin thermistor were placed onto participant’s 2 
middle and second finger, respectively, of the right hand. Participants then placed their 3 
hand into a plastic bag and immersed it to the styloid process in a water bath 4 
maintained at 35.0 (0.2) °C for five minutes. The protocol for the hand was the same as 5 
for the foot in that cooling (8.1 [0.1] °C) and spontaneous rewarming followed. Blood 6 
pressure was measured from the left arm, using an automated monitor (Minimon 7137 7 
Plus, Kontron Instruments, UK), for both the foot and hand cooling protocols and 8 
recorded two minutes prior to cooling, 30 seconds, five and 15 minutes into cooling, 9 
followed by 30 seconds and five minutes into rewarming. 10 
 11 
Participants' height and mass was measured using a stadiometer (Leicester, Bodycare, 12 
UK) and digital weighing scales (Ohaus I-10, Ohaus Corporation, USA), respectively. 13 
Length of participants' hand and foot was measured using a segmometer (Segmometer 14 
4, Rosscraft, Canada). Hand and foot volume was calculated using a water 15 
displacement method. 16 
 17 
DATA ANALYSES 18 
As mean arterial pressure (MAP = ((2*diastolic)+systolic) / 3) differed over time (see 19 
results), skin blood flow was calculated as cutaneous vascular conductance (CVC) 20 
(laser Doppler units / MAP = CVC (flux•mmHg-1)). Tsk was plotted every five minutes 21 
and, from the sampled data which was recorded every five seconds, the CIVD variables 22 
were determined which included: average Tsk, minimum Tsk, number of CIVD waves, 23 
onset time of first CIVD wave, Tsk prior to onset of first CIVD wave and maximum Tsk 24 
during the first CIVD wave and amplitude of CIVD wave (Fig. 2). For the skin blood flow 25 
assessment during local cooling and rewarming, average, minimum and area under the 26 
curve (AUC, calculated using GraphPad, Version 5, USA) were calculated. 27 
 28 
Statistical analyses were conducted using IBM SPSS for Windows version 20 (IBM 29 
SPSS Statistics, USA). Data was assessed for normality with a Shapiro-Wilk test. An α 30 
of 0.05 was used to determine statistical significance. Participant characteristics were 31 
analysed using an independent samples t-test. MAP throughout immersion was 32 
analysed between- and within-groups with a repeated measures ANOVA to identify any 33 
differences in blood pressure between ethnicities and between COX inhibition and 34 
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placebo. Where a significant main effect was observed (see results), pairwise 1 
comparisons were carried out and adjusted for multiple comparisons using the Holm-2 
Bonferroni procedure.  3 
 4 
Baseline CVC (i.e. final minute of warm water immersion) between- and within-groups 5 
was analysed using an independent and paired samples t-test, respectively. Baseline 6 
Tsk (i.e. final five seconds of warm water immersion) between- and within-groups was 7 
analysed using a Mann-Whitney U test and a Wilcoxon Signed Rank test, respectively. 8 
CIVD variables, CVC average, minimum and AUC during cooling and rewarming 9 
between-groups were analysed using either an independent samples t-test or a Mann-10 
Whitney U test. The same variables within-groups were analysed using a paired 11 
samples t-test or a Wilcoxon Signed Rank test. Between- and within-groups CVC and 12 
Tsk throughout immersion was analysed using a Mann-Whitney U and Wilcoxon Signed 13 
Rank Test, respectively, and adjusted for multiple comparisons using the Holm-14 
Bonferroni procedure.  15 
 16 
Parametric data in text is presented as mean (SD) with non-parametric data presented 17 
as median and interquartile range (IQR). Figures shown are presented as mean (SD). 18 
Effect sizes, where appropriate, were calculated and are denoted by d for parametric 19 
data and r for non-parametric data. 20 
 21 
RESULTS 22 
PARTICIPANTS 23 
All participant characteristics were similar (P > 0.05), except AFD had a longer hand 24 
length (P = 0.018, d = 1.04) and a greater hand volume (P = 0.043, d = 0.87) than CAU. 25 
 26 
MEAN ARTERIAL PRESSURE 27 
There was no main effect for ethnicity or condition (i.e. placebo vs. COX inhibition) for 28 
both foot or hand immersion protocols (mean [SD], baseline placebo, foot, CAU: 83 [5] 29 
mmHg, AFD: 83 [7] mmHg; hand, CAU: 82 [7] mmHg, AFD: 81 [8] mmHg, P > 0.05). 30 
However, there was a main effect for time for both the foot (P < 0.001) and hand (P = 31 
0.022) protocol with pairwise comparisons showing MAP being elevated for the first five 32 
minutes of immersion in the foot protocol only (Table 2). There was no statistical 33 
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interaction between condition, time and ethnicity for both immersion protocols (P > 1 
0.05). 2 
 3 
BASELINE SKIN BLOOD FLOW AND SKIN TEMPERATURE 4 
Following COX inhibition, CAU had lower baseline toe CVC (Table 3, P = 0.019, d = 5 
1.03) and Tsk (Table 3, P = 0.045, r = 0.41) than AFD. Otherwise, baseline values were 6 
similar (Table 3). 7 
 8 
FOOT RESPONSES TO COOLING AND SUBSEQUENT REWARMING 9 
SKIN BLOOD FLOW 10 
Toe skin blood flow during foot cooling and rewarming was similar between- and within-11 
groups following placebo and COX inhibition (Table 4, Fig. 3A, P > 0.05). 12 
 13 
SKIN TEMPERATURE 14 
There was a tendency for CAU to have a lower average Tsk compared with AFD 15 
following COX inhibition (Table 5, P = 0.052, d = 0.84). Following placebo, only two 16 
CAU and four AFD experienced CIVD. Following COX inhibition, only two CAU and 17 
seven AFD experienced CIVD. Therefore, analyses on these variables could not be 18 
conducted.  19 
 20 
Toe Tsk during foot cooling and rewarming was similar between- and within-groups 21 
following placebo and COX inhibition (Fig. 3B, P > 0.05). 22 
 23 
FINGER RESPONSES TO COOLING AND SUBSEQUENT REWARMING 24 
SKIN BLOOD FLOW 25 
During cooling, COX inhibition resulted in a higher minimum CVC in AFD compared with 26 
placebo (Table 6, P = 0.039, d = 0.78). During cooling, following placebo, minimum CVC 27 
was lower in AFD compared with CAU (P < 0.001, d = 2.03) whilst there was a tendency 28 
for average CVC (P = 0.050, d = 0.84) and AUC (P = 0.053, d = 0.83) to be lower in 29 
AFD compared with CAU. During rewarming AFD had lower average CVC (P = 0.009, d 30 
= 1.17) and AUC (P = 0.009, d = 1.18) compared with CAU.  31 
 32 
During cooling, following COX inhibition, there was a tendency for average CVC (P = 33 
0.052, d = 0.85) and AUC (P = 0.055, d = 0.84) to be lower in AFD compared with CAU. 34 
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During rewarming AFD experienced a lower average CVC (P < 0.001, d = 1.69), 1 
minimum CVC (P = 0.017, d = 1.05) and AUC (P = 0.001, d = 1.63) compared with 2 
CAU.  3 
 4 
During cooling and subsequent rewarming finger skin blood flow was lower in AFD than 5 
CAU following both placebo and COX inhibition (Fig. 4A).  6 
 7 
SKIN TEMPERATURE 8 
For CAU, COX inhibition resulted in a warmer average finger Tsk (Table 7, P = 0.049, r = 9 
0.28) and a faster onset time of CIVD (P = 0.035, r = 0.13) compared with placebo. 10 
Minimum finger Tsk was lower in AFD compared with CAU following both placebo (P = 11 
0.004, d = 1.30) and COX inhibition (P = 0.034, d = 0.92). 12 
 13 
Finger Tsk during cooling and rewarming was lower in AFD compared with CAU 14 
following both placebo and COX inhibition (Fig. 4B). 15 
 16 
DISCUSSION 17 
The primary findings of this study were 1) during foot cooling, toe skin blood flow (Fig. 18 
3A) and Tsk (Fig. 3B) did not differ between ethnic groups irrespective of COX inhibition, 19 
and 2) during local hand cooling AFD experienced significantly lower finger skin blood 20 
flow (Fig. 4A) and Tsk (Fig. 4B) compared with CAU irrespective of COX inhibition. 21 
Following placebo, the present study confirms previous findings between CAU and AFD 22 
in response to hand cooling (Iampietro et al., 1959; Newman, 1969; Jackson et al., 23 
1989; Maley et al., 2014), whilst the responses to foot cooling (8 °C for 30 minutes) are 24 
the first to be reported here. Contrary to our hypothesis these data suggest that in 25 
young AFD healthy males the COX pathway appears not to be the primary reason for 26 
the increased susceptibility to NFCI. 27 
 28 
During foot cooling AFD responded in a comparable manner to CAU. Given that NFCI is 29 
more prominent in the feet and AFD are more susceptible to NFCI, it was expected that 30 
CAU would respond to foot cooling with warmer Tsk and greater skin blood flow 31 
responses compared with AFD. The authors are not sure why no ethnic differences 32 
were observed in the direction expected. Thickness in skin may be a contributing factor 33 
as the authors noted that the skin on the sole of the foot in African descent participants 34 
12 
 
felt ‘thicker’. Whilst the stratum corneum thickness is similar between African and 1 
European individuals on skin sites such as the hip, arm and face (Thomson, 1955; 2 
Freeman et al., 1962; Richards et al., 2003), the deeper dermis layer is thicker in AFD 3 
(Richards et al., 2003). If the skin (epidermis or dermis) is thicker on the sole of the foot 4 
in African individuals then this may have provided some protection (insulation) from the 5 
cold stimulus and hidden a dysfunctional microvascular response. Stratum corneum 6 
thickness has been discussed previously as a factor that may influence finger cooling 7 
rates (Jay & Havenith, 2004). However, as previously observed (Maley et al., 2014), it is 8 
possible that AFD do not experience a dysfunctional response to local foot cooling 9 
without centrally-driven vasoconstriction. 10 
 11 
Interestingly, during foot cooling some participants experienced a very strong local 12 
vasoconstrictor response, whilst other exhibited only slight changes. The reason for the 13 
variability is not known. Individuals born in a tropical climate may experience 14 
exaggerated responses to local finger cooling (Lee et al., 2013), however eight out of 15 
the 12 participants in this study were born in the UK, with the four born outside the UK 16 
not primarily responsible for the variability. While participants reported similar exposure 17 
to cold, other factors, such as differences in deep body temperature (Daanen et al., 18 
1997) and physical fitness (Keramidas et al., 2010), may have contributed to the 19 
variability in responses. 20 
 21 
The present study does not lend support to a previous pilot study (Belvins et al., 2014) 22 
where it was suggested that COX inhibition in CAU may facilitate local skin blood flow 23 
during foot cooling and spontaneous rewarming. The present study employed a colder 24 
water temperature (8 °C vs. 15 °C) and one immersion of 30 minutes in comparison to 25 
three repeated immersions of ten minutes in the pilot study. Different cooling rates and 26 
duration between the two studies may have contributed to confliction in results, however 27 
further elaboration of differences between studies is not possible at present given the 28 
little information available.  29 
 30 
Using forearm and finger venous occlusion plethysmography, previous research has 31 
demonstrated the reflex vascular responses to arm or foot cooling are not altered by 32 
COX inhibition (Cowley et al., 1983, 1985; Gresele et al., 1985; Hechtman & Jageneau, 33 
1985), with one study demonstrating an increase in vascular resistance during foot 34 
13 
 
cooling (Serneri et al., 1981). As the present study observed the local vascular response 1 
(using laser Doppler flowmetry) to local cooling, the results are difficult to compare to 2 
previous studies as reflex vasoconstriction is controlled differently to local 3 
vasoconstriction (Johnson et al., 2014).  4 
 5 
As hypothesised, during hand immersion, the fingers of AFD reached a lower 6 
temperature and rewarmed more slowly than CAU, confirming our previous findings 7 
(Maley et al., 2014). We also hypothesised that COX inhibition in AFD would result in 8 
warmer finger Tsk during hand cooling and spontaneous rewarming making their 9 
response similar to CAU, although this did not occur. As alluded to within the 10 
introduction, we hoped that COX inhibition would attenuate the production of ROS and 11 
in turn reduce the vasoconstriction experienced by AFD during local hand cooling. 12 
However, the present study appears to provide evidence that COX is not the major 13 
cause for the greater vasoconstrictor response and cooler Tsk to local hand cooling in 14 
AFD. The authors can only speculate that other sources of oxidative stress, such as 15 
NADPH oxidase (Griendling & FitzGerald, 2003), are partly responsible for the 16 
exaggerated responses experienced by AFD. Anti-oxidants capable of scavenging 17 
oxygen-derived free radicals prior to cooling should be investigated in future studies.  18 
  19 
Despite COX inhibition not providing any advantage to AFD during local hand cooling, it 20 
was noted that CAU experienced a warmer average finger Tsk and earlier CIVD onset 21 
time (Table 7) following COX inhibition versus placebo. The difference in average finger 22 
Tsk was 0.6 °C and only four participants were included in the analyses for the CIVD 23 
onset time, therefore caution should be exercised when interpreting the present results. 24 
Additionally, it should be noted that COX inhibition use (e.g. acetaminophen) prior to 25 
whole-body cooling may lead to a faster decline in deep body temperature (Foster et al., 26 
2016). While COX inhibition may produce warmer finger Tsk during local cooling, the 27 
authors do not recommend administering aspirin, or any other COX inhibitor, to an 28 
individual susceptible to NFCI. 29 
 30 
Factors other than local cutaneous vasculature control may play a role in the increased 31 
susceptibility to NFCI in AFD. Previous research has shown AFD compared with CAU 32 
experience a lower deep body temperature, finger Tsk and oxygen uptake during whole-33 
body cooling (Rennie & Adams, 1957; Adams & Covino, 1958; Farnell et al., 2008). 34 
14 
 
Given that the CIVD responses are blunted with colder environments / lower deep body 1 
temperatures (Keatinge, 1957; Sawada et al., 2000; Dobnikar et al., 2009) it is possible 2 
that factors such as thermogenesis and / or centrally-driven vasoconstriction, in 3 
combination with a depressed CIVD reaction (at least in the hands) during whole-body 4 
cooling may play a role in the increased susceptibility to NFCI in AFD. Further studies 5 
are being conducted to elucidate the extremity vascular responses to whole-body 6 
cooling between CAU and AFD.  7 
 8 
It is concluded that young, healthy, male AFD and CAU show similar physiological 9 
responses to foot cooling. In contrast, compared with CAU, AFD experience lower finger 10 
skin blood flow and cooler finger Tsk in response to hand cooling irrespective of COX 11 
inhibition. Therefore, it is unlikely that the COX pathway is responsible for the increased 12 
susceptibility to NFCI in AFD.  13 
15 
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TABLES 22 
Table 1. Mean (SD) participant characteristics  23 
 Participant Characteristics 
 CAU AFD 
Age (years) 20 (4) 20 (2) 
Height (cm) 178.2 (6.9) 176.0 (7.9) 
Mass (kg) 73.1 (12.3) 74.1 (12.8) 
Hand Length (cm) 20.0 (1.1)* 21.2 (1.2) 
Foot Length (cm) 26.3 (1.2) 27.0 (1.8) 
Hand Volume (L) 0.42 (0.12)* 0.53 (0.13) 
Foot Volume (L) 1.16 (0.19) 1.24 (0.32) 
* Significant difference between CAU and AFD (P < 0.05). n = 12 for each group. 24 
 25 
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Table 2. Mean (SD) mean arterial pressure (mmHg) for the foot and hand protocol as an 1 
average of both ethnic groups in both placebo and COX inhibition trials 2 
 Mean Arterial Pressure (mmHg) 
Time Foot Hand 
Baseline 83 (7) 82 (8) 
30 seconds cooling 88 (9)* 84 (9) 
5 minutes cooling 87 (9)* 86 (9) 
15 minutes cooling 84 (6) 85 (7) 
30 seconds rewarming 85 (8) 83 (8) 
5 minutes rewarming 82 (7) 82 (7) 
* Significant difference compared with baseline (P < 0.05). 3 
 4 
Table 3. Mean (SD) or median (IQR) toe and finger cutaneous vascular conductance 5 
(flux•mmHg-1) and skin temperature (°C) at the end of warm water immersion for the 6 
foot and hand protocol following placebo or COX inhibition 7 
 Baseline Cutaneous Vascular Conductance (flux•mmHg-1) 
 Placebo COX inhibition 
Skin site CAU AFD CAU AFD 
Toe 2.2 (1.7) 3.1 (1.1) 1.8 (1.5)* 3.4 (1.7) 
Finger 4.7 (0.8) 4.8 (1.0) 4.3 (1.2) 5.1 (1.1) 
 Baseline Skin Temperature (°C) 
Toe ^ 35.1 (1.1) 35.6 (1.2) 34.8 (1.6)* 35.5 (0.6) 
Finger ^ 35.9 (0.4) 35.8 (0.2) 35.8 (0.2) 35.8 (0.1) 
^ Median (IQR). * Significant difference between CAU and AFD (P < 0.05). n = 12 for each group. 8 
 9 
Table 4. Mean (SD) or median (IQR) cutaneous vascular conductance (flux•mmHg-1) 10 
variables for the toe skin site during foot cooling and rewarming following placebo and 11 
COX inhibition 12 
  Cutaneous Vascular Conductance (flux•mmHg-1) 
  Placebo COX inhibition 
  CAU AFD CAU AFD 
Cooling 
Average 1.6 (1.7) 1.7 (1.4) 1.3 (1.3) 2.3 (1.6) 
Minimum ^ 0.2 (0.6) 0.2 (0.4) 0.1 (0.2) 0.2 (0.7) 
AUC 49 (51) 55 (43) 40 (39) 70 (51) 
Rewarming 
Average ^ 1.2 (2.8) 1.5 (2.9) 1.5 (2.3) 1.5 (3.6) 
Minimum ^ 0.2 (1.2) 0.2 (0.6) 0.3 (0.3) 0.4 (2.3) 
AUC 25 (23) 27 (22) 25 (22) 32 (32) 
^ Median (IQR). AUC = Area under the curve. n = 12 for each group. 13 
 14 
 15 
 16 
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Table 5. Mean (SD) or median (IQR) cold-induced vasodilatation variables for the toe 1 
skin site during the foot cooling protocol following placebo and COX inhibition 2 
 Placebo COX inhibition 
 CAU AFD CAU AFD 
Average Tsk (°C) 14.4 (3.4) 15.9 (4.1) 13.7 (3.1)† 16.4 (3.3) 
Minimum Tsk (°C) ^ 9.3 (4.1) 10.9 (7.8) 9.1 (2.4) 12.6 (6.6) 
 CAU (n = 2) AFD (n = 4) CAU (n = 2) AFD (n = 7) 
Number of waves 1.0 (0.0) 1.5 (0.6) 1.5 (0.7) 1.6 (0.5) 
Onset time (min) 19.3 (4.0) 3.6 (0.8) 4.8 (3.3) 4.9 (3.6) 
Tsk prior to onset of CIVD (°C) 14.0 (5.1) 19.9 (1.8) 19.6 (0.7) 18.1 (2.4) 
Max Tsk during CIVD (°C) 15.7 (5.2) 22.5 (2.1) 21.2 (1.4) 20.5 (2.0) 
Amplitude (°C) 1.7 (0.1) 2.7 (0.4) 1.7 (0.6) 2.4 (1.6) 
† P = 0.052. ^ Median (IQR). n = 12 for average and minimum Tsk. 3 
 4 
Table 6. Mean (SD) cutaneous vascular conductance variables for the finger skin site 5 
during hand cooling and rewarming following placebo and COX inhibition 6 
  Cutaneous Vascular Conductance (flux•mmHg-1) 
  Placebo COX inhibition 
  CAU AFD CAU AFD 
Cooling 
Average 2.1 (0.9) 1.4 (0.8) 2.3 (1.1) 1.6 (0.6) 
Minimum 0.8 (0.2)* 0.5 (0.1)‡ 0.9 (0.5) 0.6 (0.3) 
AUC 66 (27) 44 (24) 74 (35) 50 (18) 
Rewarming 
Average 4.3 (1.0)* 2.8 (1.6) 4.3 (0.6)* 2.8 (1.0) 
Minimum 1.5 (0.6) 1.2 (1.1) 1.6 (0.8)* 0.9 (0.5) 
AUC 66 (16)* 43 (24) 66 (10)* 45 (16) 
* Significant difference between CAU and AFD (P < 0.05). ‡ Significant difference between placebo and 7 
COX inhibition (P < 0.05). AUC = Area under the curve. n = 12 for each group. 8 
 9 
Table 7. Mean (SD) or median (IQR) cold-induced vasodilatation variables for the finger 10 
skin site during the hand cooling protocol following placebo and COX inhibition 11 
 Placebo COX inhibition 
 CAU AFD CAU AFD 
Average Tsk (°C) 14.6 (2.3)‡ 13.0 (3.0) 15.2 (2.5) 13.5 (1.9) 
Minimum Tsk (°C) 10.7 (1.3)* 9.5 (1.4) 10.4 (0.9)* 9.5 (1.2) 
 CAU (n = 7) AFD (n = 4) CAU (n = 4) AFD (n = 5) 
Number of waves ^ 1.0 (1.0) 1.0 (0.0) 2.0 (1.5) 1.0 (0.5) 
Onset time (min) 9.7 (6.2)‡ 10.7 (8.5) 6.1 (5.9) 7.3 (5.6) 
Tsk prior to onset of CIVD (°C) 13.8 (4.3) 14.1 (4.2) 15.8 (6.2) 14.9 (4.4) 
Max Tsk during CIVD (°C) 17.5 (6.2) 19.1 (3.8) 19.3 (5.6) 18.2 (5.1) 
Amplitude (°C) 3.6 (2.3) 5.0 (1.4) 3.5 (3.3) 3.3 (1.0) 
^ Median (IQR). * Significant difference between CAU and AFD (P < 0.05). ‡ Significant difference 12 
between placebo and COX inhibition (P < 0.05). n = 12 for average and minimum Tsk.13 
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 1 
FIGURE CAPTIONS 2 
Figure 1. Schematic of the experimental procedure 3 
 4 
Figure 2. Typical trace of finger skin temperature (°C) during hand immersion in water at 5 
8 °C and subsequent rewarming in air at 30 °C showing variables analysed during cold-6 
induced vasodilatation.  7 
 8 
Figure 3. Mean (SD) toe cutaneous vascular conductance (flux•mmHg-1) (a) and skin 9 
temperature (°C) (b) during foot cooling and subsequent spontaneous rewarming 10 
following placebo and COX inhibition 11 
Note: SD included for CAU Placebo protocol only for reader clarity. 12 
 13 
Figure 4. Mean (SD) finger cutaneous vascular conductance (flux•mmHg-1) (a) and skin 14 
temperature (°C) (b) during hand cooling and subsequent spontaneous rewarming 15 
following placebo and COX inhibition 16 
* Significant difference between CAU and AFD following placebo (P < 0.05). † Significant difference 17 
between CAU and AFD following COX inhibition (P < 0.05). Note: SD included for CAU Placebo protocol 18 
only for reader clarity. 19 
 20 
